Ginkgo Bioworks Holdings paid its 4 named executives $10.9M in total in FY2025 (Dec). CEO Jason Kelly was paid $5.7M of that.
PayNo stock prices for these years
Pay of each named executive
Jason KellyChief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Reshma ShettyPresident & Former Chief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Steven CoenChief Financial Officer
| FY2025 (Dec) |
1 year
Mark DmytrukFormer Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 10 peers with pay on file was $7.8M. CEO pay of Ginkgo Bioworks Holdings for that year is not on file.
- 1Twist Bioscience
- 2Ultragenyx Pharmaceutical
- 3Standard Biotools
- 4Travere Therapeutics
- 5Vir Biotechnology
- 6CRISPR Therapeutics AG
- 7AbCellera Biologics
- 8Beam Therapeutics
- 9Pacific Biosciences Of California
- 10Schrodinger
- 11Ginkgo Bioworks HoldingsThis companyNot disclosed
- 12Akoya Biosciences, Inc.Not disclosed
- 13Flotek Industries, Inc.Not disclosed
- 14Harvard Bioscience, Inc.Not disclosed
- 15Maravai Lifesciences HoldingsNot disclosed
- 16Perimeter SolutionsNot disclosed
- 17Quanterix CorporationNot disclosed
- 18Sangamo Therapeutics, Inc.Not disclosed
- 19Seres Therapeutics, Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.